Areas of scientific research interest have included: NAD metabolism and NNMT-pathway studies Obesity- and adipose-tissue regulation research Mitochondrial-function and metabolic-syndrome investigations Insulin-sensitivity and glucose-homeostasis research Longevity-, healthy-aging-, and cellular-maintenance studies Cellular-energy and metabolic-regulation pathways Oxidative-stress and mitochondrial-related research models 5-Amino-1MQ has been investigated in biochemical, metabolic, and cellular research models focused on energy regulation, mitochondrial-related pathways, and metabolic function
The combination creates a context where AOD 9604s lipolytic effect is occurring simultaneously with GH-stimulated protein synthesis and recovery, theoretically allowing fat loss and lean mass preservation to happen in parallel
Animal models exposed to 5-Amino-1MQ demonstrate accelerated lipid metabolism and extensive white adipose tissue remodelling, driven by up-regulated SIRT1 activity
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
IF binds to vitamin B12 so your body can absorb it
Can Brenda Johnson, MATS, PA-C, combine B-12 injections with other treatments
